Cardiac computed tomography and myocardial perfusion imaging for risk stratification in asymptomatic diabetic patients: A critical review

Journal of Nuclear Cardiology

Volumn 15, Issue 1, 2008, Pages 13-22

  Yerramasu, Ajay ^a   Maggae, Shreenidhi Venuraju ^a   Lahiri, Avijit ^a   Anand, Dhakshinamurthy Vijay ^a,b  

^a WELLINGTON HOSPITAL   (United Kingdom)

^b NEWHAM UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIABETIC PATIENT; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; ECONOMIC ASPECT; EDITORIAL; HEART DISEASE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART REINFARCTION; HIGH RISK PATIENT; HUMAN; MORBIDITY; MORTALITY; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCREENING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THROMBOSIS;

COMORBIDITY; DIABETES MELLITUS; HUMANS; INCIDENCE; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; VENTRICULAR DYSFUNCTION, LEFT;

EID: 38649142823     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2007.11.001     Document Type: Editorial

References (63)

1. Gu K., Cowie C.C., and Harris M.I. Mortality in adults with and without diabetes in a national cohort of the US population, 1971-1993. Diabetes Care 21 (1998) 1138-1145
2. Haffner S.M., Lehto S., Rönemaa T., Pyörälä K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339 (1998) 229-234
3. Donnan P.T., Boyle D.I., Broomhall J., Hunter K., MacDonald T.M., Newton R.W., et al. Prognosis following first acute myocardial infarction in type 2 diabetes: a comparative population study. Diabetic Med 19 (2002) 448-455
4. Herlitz J., Malmberg K., Karlson B.W., Ryden L., and Hjalmarson A. Mortality and morbidity during a five-year follow-up of diabetics with myocardial infarction. Acta Med Scand 224 (1988) 31-38
5. Bax J.J., Bonow R.O., Tschope D., Inzucchi S.E., Barrett E., and Global Dialogue Group for the Evaluation of Cardiovascular Risk in Patients With Diabetes. The potential of myocardial perfusion scintigraphy for risk stratification of asymptomatic patients with type 2 diabetes. J Am Coll Cardiol 48 (2006) 754-760
6. Miller T.D., Redberg R.F., and Wackers F.J. Screening asymptomatic diabetic patients for coronary artery disease: why not?. J Am Coll Cardiol 48 (2006) 761-764
7. Wackers F.J. Asymptomatic patients with diabetes mellitus should be screened for coronary artery disease. J Nucl Cardiol 13 (2006) 609-615
8. Gibbons R.J. Asymptomatic patients with diabetes mellitus should not be screened for coronary artery disease. J Nucl Cardiol 13 (2006) 616-620
9. Di Carli M.F., and Hachamovitch R. Should we screen for occult coronary artery disease among asymptomatic patients with diabetes [review]?. J Am Coll Cardiol 45 (2005) 50-53
10. Diamond G.A., Kaul S., and Shah P.K. Screen testing: cardiovascular prevention in asymptomatic diabetic patients. J Am Coll Cardiol 49 (2007) 1915-1917
11. Beller G. Screening for CAD in asymptomatic type 2 diabetic patients. J Am Coll Cardiol 49 (2007) 1918-1923
12. Zellweger M.J., and Pfisterer M.E. Silent coronary artery disease in patients with diabetes mellitus. Swiss Med Wkly 131 (2001) 427-432
13. Goraya T.Y., Leibson C.L., Palumbo P.J., Weston S.A., Killian J.M., Pfeifer E.A., et al. Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. J Am Coll Cardiol 40 (2002) 946-953
14. Wackers F.J., Young L.H., Inzucchi S.E., Chyun D.A., Davey J.A., Barrett E.J., et al. Detection of Ischemia in Asymptomatic Diabetics Investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD Study. Diabetes Care 27 (2004) 1954-1961
15. Rajagopalan N., Miller T.D., Hodge D.O., Frye R.L., and Gibbons R.J. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol 45 (2005) 43-49
16. Miller T.D., Rajagopalan N., Hodge D.O., Frye R.L., and Gibbons R.J. Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes. Am Heart J 147 (2004) 890-896
17. Fornengo P., Bosio A., Epifani G., Pallisco O., Mancuso A., and Pascale C. Prevalence of silent myocardial ischaemia in new-onset middle-aged type 2 diabetic patients without other cardiovascular risk factors. Diabetic Med 23 (2006) 775-779
18. Zellweger M.J., Hachamovitch R., Kang X., Hayes S.W., Friedman J.D., Germano G., et al. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. Eur Heart J 25 (2004) 543-550
19. Pancholy S.B., Schalet B., Kuhlmeier V., Cave V., Heo J., and Iskandrian A.S. Prognostic significance of silent ischemia. J Nucl Cardiol 1 (1994) 434-440
20. Weiner D.A., Ryan T.J., Parsons L., Fisher L.D., Chaitman B.R., Sheffield L.T., et al. Significance of silent myocardial ischemia during exercise testing in patients with diabetes mellitus: a report from the Coronary Artery Surgery Study (CASS) Registry. Am J Cardiol 68 (1991) 729-734
21. Nicholls S.J., Tuzcu E.M., Crowe T., Sipahi I., Schoenhagen P., Kapadia S., et al. Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound. J Am Coll Cardiol 47 (2006) 1967-1975
22. Scholte A.J., Schuijf J.D., Kharagjitsingh A.V., Jukema W., Pundziute G., van der Wall E.E., et al. Prevalence of coronary artery disease and plaque morphology assessed by multi-slice computed tomography coronary angiography and calcium scoring in asymptomatic patients with type 2 diabetes. Heart (2007) August 7; [Epub ahead of print]
23. Virmani R., Burke A.P., and Kolodgie F. Morphological characteristics of coronary atherosclerosis in diabetes mellitus. Can J Cardiol 22 Suppl B (2006) 81B-84B
24. Burke A.P., Kolodgie F.D., Zieske A., Fowler D.R., Weber D.K., Varghese P.J., et al. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol 24 (2004) 1266-1271
25. Falk E., Shah P.K., and Fuster V. Coronary plaque disruption. Circulation 92 (1995) 657-671
26. Topol E.J., and Nissen S.E. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart. Circulation 92 (1995) 2333-2342
27. Cleeman J.I., et al. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
28. Hachamovitch R., Hayes S.W., Friedman J.D., Cohen I., and Berman D.S. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 107 (2003) 2900-2907
29. Wiviott S.D., Cannon C.P., Morrow D.A., Ray K.K., Pfeffer M.A., Braunwald E., and PROVE IT-TIMI 22 Investigators. Can low-density lipoprotein be too low?. The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy. J Am Coll Cardiol 46 (2005) 1411-1416
30. Raggi P., Callister T.Q., Cooil B., He Z.X., Lippolis N.J., Russo D.J., et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 101 (2000) 850-855
31. Arad Y., Spadaro L.A., Goodman K., Newstein D., and Guerci A.D. Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol 36 (2000) 1253-1260
32. Wong N.D., Hsu J.C., Detrano R.C., Diamond G., Eisenberg H., and Gardin J.M. Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events. Am J Cardiol 86 (2000) 495-498
33. Kondos G.T., Hoff J.A., Sevrukov A., Daviglus M.L., Garside D.B., Devries S.S., et al. Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation 107 (2003) 2571-2576
34. Shaw L.J., Raggi P., Schisterman E., Berman D., and Callister T.Q. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 228 (2003) 826-833
35. Raggi P., Shaw L.J., Berman D.S., and Callister T.Q. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol 43 (2004) 1663-1669
36. LaMonte M.J., FitzGerald S.J., Church T.S., Barlow C.E., Radford N.B., Levine B.D., et al. Coronary artery calcium score and coronary heart disease events in a large cohort of asymptomatic men and women. Am J Epidemiol 162 (2005) 421-429
37. Budoff M.J., Shaw L.J., Liu S.T., Weinstein S.R., Mosler T.P., Tseng P.H., et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol 49 (2007) 1860-1870
38. Detrano R.C., Wong N.D., Doherty T.M., Shavelle R.M., Tang W., Ginzton L.E., et al. Coronary calcium does not accurately predict near-term future coronary events in high-risk adults. Circulation 99 (1999) 2633-2638
39. Qu W., Le T.T., Azen S.P., Xiang M., Wong N.D., Doherty T.M., et al. Value of coronary artery calcium scanning by computed tomography for predicting coronary heart disease in diabetic subjects. Diabetes Care 26 (2003) 905-910
40. Greenland P., LaBree L., Azen S.P., Doherty T.M., and Detrano R.C. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 291 (2004) 210-215
41. Arad Y., Goodman K.J., Roth M., Newstein D., and Guerci A.D. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol 46 (2005) 158-165
42. Vliegenthart R., Oudkerk M., Hofman A., Oei H.H., van Dijck W., van Rooij F.J., et al. Coronary calcification improves cardiovascular risk prediction in the elderly. Circulation 112 (2005) 572-577
43. Taylor A.J., Bindeman J., Feuerstein I., Cao F., Brazaitis M., and O'Malley P.G. Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) Project. J Am Coll Cardiol 46 (2005) 807-814
44. Anand D.V., Lim E., Hopkins D., Corder R., Shaw L.J., Sharp P., et al. Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J 27 (2006) 713-721
45. Raggi P., Callister T.Q., and Shaw L.J. Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy. Arterioscler Thromb Vasc Biol 24 (2004) 1272-1277
46. Raggi P., Cooil B., Ratti C., Callister T.Q., and Budoff M. Progression of coronary artery calcium and occurrence of myocardial infarction in patients with and without diabetes mellitus. Hypertension 46 (2005) 238-243
47. Kronmal R.A., McClelland R.L., Detrano R., Shea S., Lima J.A., Cushman M., et al. Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 115 (2007) 2722-2730
48. Anand D.V., Lim E., Darko D., Bassett P., Hopkins D., Lipkin D., et al. Determinants of progression of coronary artery calcification in type 2 diabetes: role of glycemic control and inflammatory/vascular calcification markers. J Am Coll Cardiol 50 (2007) 2218-2225
49. Anand D.V., Lim E.T.S., Darko D., Hopkins D., Corder R., Lipkin D., et al. Progression of coronary atherosclerosis is related to increasing burden of silent myocardial ischaemia in type 2 diabetes. [abstract]. J Nucl Cardiol 14 Suppl 1 (2007) S35
50. Snell-Bergeon J.K., Hokanson J.E., Jensen L., MacKenzie T., Kinney G., Dabelea D., et al. Progression of coronary artery calcification in type 1 diabetes: the importance of glycemic control. Diabetes Care 26 (2003) 2923-2928
51. Iskander S., and Iskandrian A.E. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 32 (1998) 57-62
52. Mowatt G., Brazzelli M., Gemmell H., Hillis G.S., Metcalfe M., Vale L., and Aberdeen Technology Assessment Review Group. Systematic review of the prognostic effectiveness of SPECT myocardial perfusion scintigraphy in patients with suspected or known coronary artery disease and following myocardial infarction. Nucl Med Commun 26 (2005) 217-229
53. Berman D.S., Kang X., Hayes S.W., Friedman J.D., Cohen I., Abidov A., et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men: impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol 41 (2003) 1125-1133
54. Berman D.S., Schisterman E.F., Miranda R., Friedman J.D., Hayes S.W., Lewin H.C., et al. Nuclear cardiology and electron-beam computed tomography: competitive or complementary?. Am J Cardiol 88 Suppl (2001) 51E-55E
55. Ramakrishna G., Miller T.D., Breen J.F., Araoz P.A., Hodge D.O., and Gibbons R.J. Relationship and prognostic value of coronary artery calcification by electron beam computed tomography to stress-induced ischemia by single photon emission computed tomography. Am Heart J 153 (2007) 807-814
56. Lim E., and Lahiri A. The importance of the link between coronary artery calcification and myocardial ischemia: a developing argument. J Nucl Cardiol 14 (2007) 272-274
57. Kamalesh M., Feigenbaum H., and Sawada S. Challenge of identifying patients with diabetes mellitus who are at low risk for coronary events by use of cardiac stress imaging. Am Heart J 147 (2004) 561-563
58. Kamalesh M., Feigenbaum H., and Sawada S. Assessing prognosis in patients with diabetes mellitus-the Achilles' heel of cardiac stress imaging tests?. Am J Cardiol 99 (2007) 1016-1019
59. Schinkel A.F., Elhendy A., van Domburg R.T., Bax J.J., Vourvouri E.C., Sozzi F.B., et al. Prognostic value of dobutamine-atropine stress myocardial perfusion imaging in patients with diabetes. Diabetes Care 25 (2002) 1637-1643
60. Giri S., Shaw L.J., Murthy D.R., Travin M.I., Miller D.D., Hachamovitch R., et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 105 (2002) 32-40
61. Rozanski A., Gransar H., Wong N.D., Shaw L.J., Miranda-Peats R., Polk D., et al. Clinical outcomes after both coronary calcium scanning and exercise myocardial perfusion scintigraphy. J Am Coll Cardiol 49 (2007) 1352-1361
62. Levin D.C., Parker L., Intenzo C.M., and Sunshine J.H. Recent rapid increase in utilization of radionuclide myocardial perfusion imaging and related procedures: 1996-1998 practice patterns. Radiology 222 (2002) 144-148
63. Lakoski S.G., Cushman M., Blumenthal R.S., Kronmal R., Arnett D., D'Agostino Jr. R.B., et al. Implications of C-reactive protein or coronary artery calcium score as an adjunct to global risk assessment for primary prevention of CHD. Atherosclerosis 193 (2007) 401-407